Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for IMNN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -3.131M
March 31, 2026 0.00
December 31, 2025 -7.191M
September 30, 2025 -4.963M
June 30, 2025 -4.826M
March 31, 2025 -0.1057M
December 31, 2024 0.0033M
September 30, 2024 -9.064M
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 -0.0302M
September 30, 2023 -0.0783M
June 30, 2023 -0.1986M
March 31, 2023 -2.474M
December 31, 2022 -0.4473M
September 30, 2022 0.064M
June 30, 2022 -6.339M
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 5.765M
June 30, 2021 -19.51M
March 31, 2021 -40.46M
December 31, 2020 -2.561M
September 30, 2020 -2.068M
June 30, 2020 -12.76M
Date Value
March 31, 2020 -5.795M
December 31, 2019 -1.669M
September 30, 2019 -1.712M
June 30, 2019 -2.709M
March 31, 2019 -1.755M
December 31, 2018 0.3781M
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 -1.237M
December 31, 2017 -25.72M
September 30, 2017 -4.163M
June 30, 2017 -4.745M
March 31, 2017 -4.423M
December 31, 2016 -1.349M
September 30, 2016 0.0014M
June 30, 2016 -5.430M
March 31, 2016 0.00
December 31, 2015 -0.5734M
September 30, 2015 0.0867M
June 30, 2015 -7.250M
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.0364M
March 31, 2014 -13.83M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Phio Pharmaceuticals Corp. 0.00
Agenus, Inc. -14.71M
Amgen, Inc. 0.00
Anika Therapeutics, Inc. 0.643M
BioCryst Pharmaceuticals, Inc. -6.247M